Search

Author/Creator Stroud, Chad

1. A phase IV clinical trial of gastrointestinal motility in adult patients with migraine before and after initiation of a calcitonin gene‐related peptide ligand (galcanezumab) or receptor (erenumab) antagonist. Issue 9 (16th September 2022)

Authors:
Kudrow, David; Nguyen, Linda; Semler, Jack; Stroud, Chad; Samaan, Karen; Hoban, Deirdre B.; Wietecha, Linda; Hsu, Hai‐An; Pearlman, Eric
Journal:
Headache
Issue:
Volume 62:Issue 9(2022)
Page Start:
1164
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Tolerability and safety of galcanezumab in patients with chronic cluster headache with up to 15 months of galcanezumab treatment. Issue 1 (22nd November 2021)

Authors:
Láinez, Miguel J. A.; Schoenen, Jean; Stroud, Chad; Bardos, Jennifer; Bangs, Mark; Kemmer, Phebe; Wenzel, Richard; Kuruppu, Dulanji K.; Martinez, James Michael; Oakes, Tina M.
Journal:
Headache
Issue:
Volume 62:Issue 1(2022)
Page Start:
65
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

Limit your search